Phase I/II study of bortezomib‐melphalan‐prednisolone for previously untreated Japanese patients with multiple myeloma

This phase I/II study was conducted to evaluate the safety and efficacy of bortezomib‐melphalan‐prednisolone in Japanese patients with previously untreated multiple myeloma who are ineligible for hematopoietic stem cell transplantation. One hundred and one patients were enrolled, and 99 patients rec...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Sci
Main Authors: Ogawa, Yoshiaki, Suzuki, Kenshi, Sakai, Akira, Iida, Shinsuke, Ogura, Michinori, Tobinai, Kensei, Matsumoto, Morio, Matsue, Kosei, Terui, Yasuhito, Ohashi, Kazuteru, Ishii, Masami, Mukai, Harumi Y., Ando, Kiyoshi, Hotta, Tomomitsu
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2013
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657225/
https://ncbi.nlm.nih.gov/pubmed/23574271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12172
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker